Table 3.
Estimated Incidence Rates (per 100,000 dog-years at risk) of the most common types of benign and malignant cytologically diagnosed tumours in the Golden retriever compared to Incidence Rates (per 100,000 dog-years at risk) found in previous studies concerning the general dog population
| Cytological data-set | EIR Utrecht | Incidence rate Madison, Wisconsin [38] | (Standardized) Incidence rate UK [34] | Incidence rate Genoa, Italy [30] | Incidence rate Alameda, Contra Costa [32] |
|---|---|---|---|---|---|
| General development of tumour |
1,232 |
|
2,671 |
760 |
|
| Development of cancer |
586 |
|
748 |
310 |
381 |
| ‘Fat, suspect lipoma’ |
429 |
|
318 |
|
|
| MCT |
265 |
|
129 |
|
|
| NHL |
121 |
25 |
114 |
19.9 (Males) |
21.7 |
| and 22.9 (Females) | |||||
| Perianal gland tumour |
68 |
|
|
|
|
| (Adeno) carcinoma |
37 |
|
|
|
|
| Mesenchymal proliferation, susp. STS |
37 |
35 |
142 |
|
36 |
| CCH |
30 |
|
377 |
|
|
| Melanoma | 27 | 25 | 0.7 (Males) 0.6 (Females) | 25 |